G71.13
Myotonic chondrodystrophy
Clinical Classification Guidelines
Inclusion Terms
- Chondrodystrophic myotonia
- Congenital myotonic chondrodystrophy
- Schwartz-Jampel disease
Medical Intelligence & Overview
Myotonic chondrodystrophy, also known as chondrodystrophic myotonia or Schwartz-Jampel disease, is a rare genetic disorder characterized by muscle stiffness (myotonia) and skeletal abnormalities. It affects the development and function of muscles and bones, leading to a range of physical challenges. This condition typically appears from birth and requires comprehensive management to improve quality of life and address associated health issues.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting muscle and skeletal development Inheritance patterns, often autosomal recessive, involving mutations in specific genes such as HSPG2 Presence of familial history indicating inherited predisposition
Key Symptoms: Muscle stiffness or myotonia, which can interfere with movement Delayed motor milestones in infants and children Difficulty in relaxing muscles after contraction Distinct facial features, such as a camel-shaped face or limited facial expressions Skeletal abnormalities like short stature, scoliosis (curved spine), or joint contractures Hypotonia or decreased muscle tone in early infancy Potential respiratory issues due to weak or stiff muscles Lack of smooth coordination in movements
Diagnostic & Treatment
Diagnosis Path: Diagnosis is often based on clinical observations of characteristic physical features and muscle function. Confirmatory testing may include genetic analysis to identify specific gene mutations associated with the condition. Additional assessments, such as electromyography (EMG), can evaluate muscle activity, and imaging studies like X-rays can reveal skeletal deformities.
Treatment Protocols: There is currently no cure for myotonic chondrodystrophy. Treatment strategies aim to manage symptoms and improve mobility and quality of life, including:
Clinical Advice & FAQs
Billing Guidance
Is G71.13 a billable ICD-10 code?
Yes, G71.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.13?
Clinical documentation must specify the nature of Myotonic chondrodystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference